Skip to content

Pharmaceutical Development Services

Dedicated to Manufacturable, Scalable, Market-Ready Products

Bringing a topical or non-sterile liquid product from idea to market requires more than formulation skill. It requires a partner who understands how early scientific decisions impact manufacturability, regulatory strategy, cost of goods, patient performance, and long-term commercial success.

At CPL, our Pharmaceutical Development Services (PDS) team serves as the starting point for customers requiring formulation and development services, whether you arrive with only an API, a target product profile, or a formulation that needs optimization, troubleshooting, or scale-up. With decades of specialized experience, our industry-leading Skin Lab, and a fully integrated development-to-commercial model, CPL provides a predictable, science-driven pathway from concept to clinic and beyond.

Product & Formulation Development

Where candidate molecules evolve into stable, effective, and patient-ready formulations.

Learn More

Manufacturability & Process Development

Where formulations are transformed into scalable, reproducible, commercially viable processes.

Learn More
CPL Solution

Complexity, Variability & Risk Across the Development Lifecycle

Industry Challenge

Complex rheology and physical behavior impact product quality and patient experience.

Specialized formulation and analytical expertise for complex rheology.

CPL’s teams develop and test formulations using rheology, viscosity, microstructure profiling, and performance analytics, designed explicitly for semi-solids and non-sterile liquids.

Industry Challenge

Alcohol-containing and hormone-based formulations introduce safety, handling, and process complexity.

Purpose-built infrastructure and deep experience with sensitive formulations.

CPL has dedicated handling controls, safety systems, and technical expertise for alcohol-based products, hormone-containing drugs, and other specialized formulations.

Industry Challenge

Skin permeability and topical performance must be demonstrated through IVRT and IVPT.

Integrated Skin Lab with IVPT and GMP IVRT method development and execution.

CPL correlates formulation attributes with in vitro permeation data to guide optimization, formulation selection, support regulatory filings, and build performance justification based on in vitro release data.

Industry Challenge

Formulations behave differently at scale, creating risk during technology transfer and early manufacturing.

Early manufacturability assessment is built into the development process.

CPL aligns formulation and process development from the outset, ensuring scalability through equipment-matched process parameters and predictive scale-up strategies.

Industry Challenge

Regulatory pathways require robust analytical methods, stability profiles, and complete documentation.

Phase-appropriate analytical method development, validation, and stability programs.

CPL generates the data packages regulators expect, ensuring strong method readiness, stability insights, and documentation that supports IND/ANDA/NDA pathways.
CPL’s Solution

Expertise Focused Entirely on Semi-Solids and Non-Sterile Liquids

CPL’s Pharmaceutical Development Services (PDS) combine formulation science, analytical expertise, manufacturability assessment, and phase-appropriate process development into a single, tightly connected engine. This integrated model reduces rework, compresses timelines, and ensures your product is designed not just to work in the lab, but to scale reliably into GMP manufacturing.

Product & Formulation Development

From Molecule to a Stable, Effective, and Regulatory-Ready Formulation

Learn More

Semi-solids, including ointments, creams, gels, and lotions

Suspensions, solutions, and non-sterile liquid formulations, including nasal and topical sprays

Hormone-based and alcohol-containing formulations

Pediatric and patient compliance-driven dosage forms

Pre-formulation and excipient compatibility

Drug formulation development aligned with regulatory and product performance expectations

Prototype development and QbD-informed design

Analytical method readiness

Manufacturability & Process Development

Designing a Scalable, Robust, and Commercially Viable Process

Learn More

Manufacturability assessments for semi-solids and non-sterile liquids

Process design aligned with commercial equipment and plant capability

Defining process parameters including mixing, heating, shear, cooling, and homogenization

Batch-size scaling strategies and yield optimization

Early-stage process validation planning and documentation

Linkage to phase-appropriate tech transfer and GMP manufacturing

Why Choose CPL Pharmaceutical Development Services

Single-Source Continuity Reduces Total Timeline

With development, analytical and microbiological testing, clinical supply, and commercial manufacturing under one roof, CPL eliminates handoffs and streamlines decision-making

Dedicated Project Management

Our project managers are your single point of contact and sit inside PDS, ensuring communication is proactive, transparent, and scientifically aligned

Built for Transfer to Commercial Manufacturing

Because PDS operates inside a commercial CDMO, everything we develop is grounded in reality: equipment capability, scale-up behavior, yield optimization, and long-term supply reliability

Skin Lab for IVPT & GMP IVRT Testing

Our in-house skin testing capabilities accelerate product understanding and reduce the risk of regulatory submissions, a service few CDMOs can offer

Commitment.
Partnership. Legacy.

Leverage CPL’s 35 years of expertise in non-sterile liquids and semi-solids to ensure your program's success. We’ll support your product from molecule to market, or step in at any stage of its product lifecycle.

Partner with Us
man